Full name :
First name :
Mail :
Zip Code :
City :
Country :
Email :
Phone :
Fax :
Website :
Directory :
| Title : Strategic Approaches to Target the Enzymes using Natural Compounds for the Management of Alzheimer's Disease: A Review - Ahmad_2022_CNS.Neurol.Disord.Drug.Targets_21_610 |
| Author(s) : Ahmad SS , Younis K , Philippe J , Aschner M , Khan H |
| Ref : CNS Neurol Disord Drug Targets , 21 :610 , 2022 |
| Abstract : Ahmad_2022_CNS.Neurol.Disord.Drug.Targets_21_610 |
| ESTHER : Ahmad_2022_CNS.Neurol.Disord.Drug.Targets_21_610 |
| PubMedSearch : Ahmad_2022_CNS.Neurol.Disord.Drug.Targets_21_610 |
| PubMedID: 34382514 |
| Title : Emetine and Indirubin- 3- monoxime interaction with human brain acetylcholinesterase: A computational and statistical analysis - Ahmad_2022_Cell.Mol.Biol.(Noisy-le-grand)_67_106 |
| Author(s) : Ahmad SS , Khan H , Khalid M , Almalki AS |
| Ref : Cellular & Molecular Biology (Noisy-le-grand) , 67 :106 , 2022 |
| Abstract : Ahmad_2022_Cell.Mol.Biol.(Noisy-le-grand)_67_106 |
| ESTHER : Ahmad_2022_Cell.Mol.Biol.(Noisy-le-grand)_67_106 |
| PubMedSearch : Ahmad_2022_Cell.Mol.Biol.(Noisy-le-grand)_67_106 |
| PubMedID: 35809297 |
| Title : Study of Nutraceuticals and Phytochemicals for the Management of Alzheimer's Disease: A Review - Ahmad_2021_Curr.Neuropharmacol__ |
| Author(s) : Ahmad SS , Khalid M , Kamal MA , Younis K |
| Ref : Curr Neuropharmacol , : , 2021 |
| Abstract : Ahmad_2021_Curr.Neuropharmacol__ |
| ESTHER : Ahmad_2021_Curr.Neuropharmacol__ |
| PubMedSearch : Ahmad_2021_Curr.Neuropharmacol__ |
| PubMedID: 33588732 |
| Title : Natural Products in Therapeutic Management of Multineurodegenerative Disorders by Targeting Autophagy - Shaikh_2021_Oxid.Med.Cell.Longev_2021_6347792 |
| Author(s) : Shaikh S , Ahmad K , Ahmad SS , Lee EJ , Lim JH , Beg MMA , Verma AK , Choi I |
| Ref : Oxid Med Cell Longev , 2021 :6347792 , 2021 |
| Abstract : Shaikh_2021_Oxid.Med.Cell.Longev_2021_6347792 |
| ESTHER : Shaikh_2021_Oxid.Med.Cell.Longev_2021_6347792 |
| PubMedSearch : Shaikh_2021_Oxid.Med.Cell.Longev_2021_6347792 |
| PubMedID: 34557265 |
| Title : Biocomputational Screening of Natural Compounds against Acetylcholinesterase - Ahmad_2021_Molecules_26_ |
| Author(s) : Ahmad SS , Khan MB , Ahmad K , Lim JH , Shaikh S , Lee EJ , Choi I |
| Ref : Molecules , 26 : , 2021 |
| Abstract : Ahmad_2021_Molecules_26_ |
| ESTHER : Ahmad_2021_Molecules_26_ |
| PubMedSearch : Ahmad_2021_Molecules_26_ |
| PubMedID: 33946559 |
| Title : Ajmalicine and its Analogues against AChE and BuChE for the Management of Alzheimer's Disease: An In-silico study - Liu_2020_Curr.Pharm.Des__ |
| Author(s) : Liu S , Dang M , Lei Y , Ahmad SS , Khalid M , Kamal MA , Chen L |
| Ref : Curr Pharm Des , : , 2020 |
| Abstract : Liu_2020_Curr.Pharm.Des__ |
| ESTHER : Liu_2020_Curr.Pharm.Des__ |
| PubMedSearch : Liu_2020_Curr.Pharm.Des__ |
| PubMedID: 32264807 |
| Title : Molecular interaction of human brain acetylcholinesterase with a natural inhibitor huperzine-B: an enzoinformatics approach - Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487 |
| Author(s) : Alam A , Shaikh S , Ahmad SS , Ansari MA , Shakil S , Rizvi SM , Imran M , Haneef M , Abuzenadah AM , Kamal MA |
| Ref : CNS Neurol Disord Drug Targets , 13 :487 , 2014 |
| Abstract : Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487 |
| ESTHER : Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487 |
| PubMedSearch : Alam_2014_CNS.Neurol.Disord.Drug.Targets_13_487 |
| PubMedID: 24059299 |
| Title : Current acetylcholinesterase-inhibitors: a neuroinformatics perspective - Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391 |
| Author(s) : Shaikh S , Verma A , Siddiqui S , Ahmad SS , Rizvi SM , Shakil S , Biswas D , Singh D , Siddiqui MH , Tabrez S , Kamal MA |
| Ref : CNS Neurol Disord Drug Targets , 13 :391 , 2014 |
| Abstract : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391 |
| ESTHER : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391 |
| PubMedSearch : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_391 |
| PubMedID: 24059296 |
| Title : Prediction of comparative inhibition efficiency for a novel natural ligand, galangin against human brain acetylcholinesterase, butyrylcholinesterase and 5-lipoxygenase: a neuroinformatics study - Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_452 |
| Author(s) : Shaikh S , Ahmad SS , Ansari MA , Shakil S , Rizvi SM , Tabrez S , Akhtar S , Kamal MA |
| Ref : CNS Neurol Disord Drug Targets , 13 :452 , 2014 |
| Abstract : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_452 |
| ESTHER : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_452 |
| PubMedSearch : Shaikh_2014_CNS.Neurol.Disord.Drug.Targets_13_452 |
| PubMedID: 24059300 |